DexCom, Inc. (DXCM) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は San Diego, CA, アメリカ. 現CEOは Jacob Steven Leach.
DXCM を有する IPO日 2005-04-14, 10,200 名の正社員, に上場 NASDAQ Global Select, 時価総額 $24.55B.
DexCom, Inc. is a medical device company headquartered in San Diego, California, specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management. The company's product portfolio includes the DexCom G6 integrated CGM system, DexCom ONE for replacing traditional finger-stick blood glucose testing, DexCom Share for remote monitoring, and the Dexcom Real-Time API that enables third-party developers to integrate CGM data into digital health applications. DexCom markets its solutions directly to endocrinologists, physicians, diabetes educators, and healthcare providers across the United States and internationally, with the next-generation G7 system under development. The company also partners with Verily Life Sciences to develop advanced blood-based and interstitial glucose monitoring products.
